317 related articles for article (PubMed ID: 11057794)
1. Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration.
Ververs TF; van Dijk A; Vinks SA; Blankestijn PJ; Savelkoul JF; Meulenbelt J; Boereboom FT
Crit Care Med; 2000 Oct; 28(10):3412-6. PubMed ID: 11057794
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration.
Giles LJ; Jennings AC; Thomson AH; Creed G; Beale RJ; McLuckie A
Crit Care Med; 2000 Mar; 28(3):632-7. PubMed ID: 10752806
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
Boereboom FT; Ververs FF; Blankestijn PJ; Savelkoul TJ; van Dijk A
Intensive Care Med; 1999 Oct; 25(10):1100-4. PubMed ID: 10551965
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermittent bolus administration.
Jamal JA; Mat-Nor MB; Mohamad-Nor FS; Udy AA; Wallis SC; Lipman J; Roberts JA
Int J Antimicrob Agents; 2015 Jan; 45(1):41-5. PubMed ID: 25455853
[TBL] [Abstract][Full Text] [Related]
6. Correlation of meropenem plasma levels with pharmacodynamic requirements in critically ill patients receiving continuous veno-venous hemofiltration.
Krueger WA; Neeser G; Schuster H; Schroeder TH; Hoffmann E; Heininger A; Dieterich HJ; Forst H; Unertl KE
Chemotherapy; 2003 Dec; 49(6):280-6. PubMed ID: 14671427
[TBL] [Abstract][Full Text] [Related]
7. Meropenem dosing in critically ill patients with sepsis receiving high-volume continuous venovenous hemofiltration.
Bilgrami I; Roberts JA; Wallis SC; Thomas J; Davis J; Fowler S; Goldrick PB; Lipman J
Antimicrob Agents Chemother; 2010 Jul; 54(7):2974-8. PubMed ID: 20479205
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetics of meropenem administered with prolonged infusion time in patients receiving continuous veno-venous hemofiltration].
Bo SN; Li HL; Zhu X; Yao GQ; Hu YF; Zhai SD; Lu W; Wang SY; Xu YZ; He B
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Mar; 24(3):145-8. PubMed ID: 22401158
[TBL] [Abstract][Full Text] [Related]
9. Single-dose pharmacokinetics of meropenem during continuous venovenous hemofiltration.
Thalhammer F; Schenk P; Burgmann H; El Menyawi I; Hollenstein UM; Rosenkranz AR; Sunder-Plassmann G; Breyer S; Ratheiser K
Antimicrob Agents Chemother; 1998 Sep; 42(9):2417-20. PubMed ID: 9736573
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of meropenem in critically ill patients undergoing continuous renal replacement therapy.
Isla A; Rodríguez-Gascón A; Trocóniz IF; Bueno L; Solinís MA; Maynar J; Sánchez-Izquierdo JA; Pedraz JL
Clin Pharmacokinet; 2008; 47(3):173-80. PubMed ID: 18307371
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis.
Kielstein JT; Czock D; Schöpke T; Hafer C; Bode-Böger SM; Kuse E; Keller F; Fliser D
Crit Care Med; 2006 Jan; 34(1):51-6. PubMed ID: 16374156
[TBL] [Abstract][Full Text] [Related]
12. Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.
Roberts DM; Roberts JA; Roberts MS; Liu X; Nair P; Cole L; Lipman J; Bellomo R;
Crit Care Med; 2012 May; 40(5):1523-8. PubMed ID: 22511133
[TBL] [Abstract][Full Text] [Related]
13. The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens*.
Jamal JA; Udy AA; Lipman J; Roberts JA
Crit Care Med; 2014 Jul; 42(7):1640-50. PubMed ID: 24674926
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic modeling and dosage adaptation of biapenem in Japanese patients during continuous venovenous hemodiafiltration.
Ikawa K; Morikawa N; Ikeda K; Suyama H
J Infect Chemother; 2008 Feb; 14(1):35-9. PubMed ID: 18297447
[TBL] [Abstract][Full Text] [Related]
15. Elimination of meropenem during continuous veno-venous haemofiltration and haemodiafiltration in patients with acute renal failure.
Valtonen M; Tiula E; Backman JT; Neuvonen PJ
J Antimicrob Chemother; 2000 May; 45(5):701-4. PubMed ID: 10797097
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of meropenem in children receiving continuous renal replacement therapy: Validation of clinical trial simulations.
Nehus EJ; Mizuno T; Cox S; Goldstein SL; Vinks AA
J Clin Pharmacol; 2016 Mar; 56(3):291-7. PubMed ID: 26222329
[TBL] [Abstract][Full Text] [Related]
17. Multiple-dose pharmacokinetics of daptomycin during continuous venovenous haemodiafiltration.
Wenisch JM; Meyer B; Fuhrmann V; Saria K; Zuba C; Dittrich P; Thalhammer F
J Antimicrob Chemother; 2012 Apr; 67(4):977-83. PubMed ID: 22210754
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of meropenem in critically ill patients with severe infections.
Binder L; Schwörer H; Hoppe S; Streit F; Neumann S; Beckmann A; Wachter R; Oellerich M; Walson PD
Ther Drug Monit; 2013 Feb; 35(1):63-70. PubMed ID: 23318279
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and Pharmacodynamics of Extended-Infusion Cefepime in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Prospective, Open-Label Study.
Philpott CD; Droege CA; Droege ME; Healy DP; Courter JD; Ernst NE; Harger NJ; Foertsch MJ; Winter JB; Carter KE; Van Fleet SL; Athota K; Mueller EW
Pharmacotherapy; 2019 Nov; 39(11):1066-1076. PubMed ID: 31549737
[TBL] [Abstract][Full Text] [Related]
20. Effect of continuous venovenous hemofiltration with dialysis on hormone and catecholamine clearance in critically ill patients with acute renal failure.
Bellomo R; McGrath B; Boyce N
Crit Care Med; 1994 May; 22(5):833-7. PubMed ID: 8181293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
